Skip to main content
. 2016 Feb 4;46(4):323–328. doi: 10.1093/jjco/hyw001

Table 1.

Clinicopathologic characteristics

Characteristic LAG (n = 101) OG (n = 101) P value
Age, mean, year ± SD 57.7 ± 10.5 59.9 ± 10.1 0.163
Gender 1.000
 Male 54 (53.5%) 53 (52.5%)
 Female 47 (46.5%) 48 (47.5%)
BMI, mean, kg/m2± SD 23.7 ± 1.1 23.7 ± 1.0 0.459
Comorbidity 27 (26.7) 31 (30.7) 0.571
ASA score 0.923
 1 29 (28.7%) 28 (27.7%)
 2 54 (53.5%) 52 (51.5%)
 3 18 (17.8%) 21 (20.8%)
TNM stage 0.528
 II 58 (57.4%) 60 (59.4%)
 III a 24 (23.8%) 23 (22.8%)
 III b 19 (18.8%) 18 (17.8%)
Tumor location 1.000
 Upper 62 (61.4%) 62 (61.4%)
 Middle 10 (9.9%) 10 (9.9%)
 Distal 29 (28.7%) 29 (28.7%)
Operation mode 1.000
 Total 63 (62.4%) 63 (62.4%)
 Distal 38 (37.6%) 38 (37.6%)
Pathology 0.845
 Undifferentiated 58 (57.4%) 60 (59.4%)
 Differentiated 43 (42.6%) 41 (40.6%)

Data are presented as mean ± standard deviation or n (%).

ASA, American Society of Anesthesiologists; TNM, tumor, node, metastasis classification staging system, LAG, laparoscopy-assisted gastrectomy; OG, open gastrectomy.